Now loading.
Please wait.

Menu

+91-11-23736906

htain-dhr@nic.in

List of Completed Studies

HomeVirtual LibraryList of Completed Studies
HomeVirtual LibraryList of Completed Studies

List of Completed Studies

By Chronology

2018

2019

    • 3.Health Technology Assessment of strategies for Cervical Cancer Screening in India. (PGIMER Chandigarh).

    • 4. Expanding Informed Contraceptive Choice for Indian Women: Health Technology Assessment of Long Acting Reversible Contraceptives (LARC) in India. (NIRRH, Mumbai)

    • 5. Diagnostic efficacy of digital Hemoglobinometer (TrueHb), Hemocue and non-invasive devices for screening patients for Anemia in the field settings. (IIPH, Delhi)

    • 6. Costing of Healthcare services in India (CHSI) Phase -1. (PGI Chandigarh)

    • 7. Device specification & Quality assurance guidelines for Blood Pressure, Blood Glucose & BMI measuring devices. (SCTIMST, Trivandrum,2019)

2020

    • 8.Cost effectiveness analysis of Hypothermia detection devices (BEPMU), Thermospot and Fever Watch) for pre-mature and low birth weight neonates in India. (IIPH Shillong)

    • 9. Health Technology Assessment of Uterine Balloon Tamponade for Management of Postpartum Haemorrhage in India. (NIRRH, Mumbai)

    • 10. Health Technology Assessment of portable automated ABR neonatal hearing screening device (Sohum). (RMRC, Bhubaneshwar)

    • 11.Rapid Health Technology Assessment for incorporating TrueNat as a diagnostic tool for tuberculosis under NTEP in India. (HTAIn Secretariat)

    • 12. Evaluation of Pulse Oximetry as a tool to prevent childhood pneumonia related morbidity and mortality. (SCTIMST, Trivandrum)

    • 13.Health Technology Assessment of Automated Resuscitation Device for Neonatal Resuscitation at point of delivery in Indian healthcare system. (KIHT, Vizag, Vishakhapatnam)

    • 14. Health Technology Assessment of various RT-PCR kits for the diagnosis of Influenza A/H1N1-pdm09 virus in all age patients in India. (NIV, Pune)

    • 15. Health Technology Assessment for screening of Type-2 Diabetes & Hypertension in India. (PGIMER Chandigarh)

2021

    • 16. Health Technology Assessment for screening of Hepatitis B and C at Primary Health Centres (PHC) in Tamil Nadu. (NIRT, Chennai)

    • 17. A comprehensive HTA of Project Lifeline - A portable ECG facility at PHCs of Ahmedabad district of Gujarat. (IIPH, Gandhinagar)

    • 18. Health Technology Assessment of Low Cost Portable Ventilators. (KIHT, Vishakhapatnam)

    • 19. Economic Evaluation of Percutaneous Coronary Intervention(PCI) in comparison to Coronary Artery Bypass Graft (CABG) surgery in Left main with or without Triple Vessel Disease. (HTAIn Secretariat)

    • 20. Economic Evaluation of Percutaneous Coronary Intervention(PCI) in comparison to Optimal Medical Therapy(OMT) for the management of patients with Single-Vessel Disease without left main coronary artery involvement. (HTAIn Secretariat)

    • 21. Economic Evaluation of Coronary Artery Bypass Graft surgery and Percutaneous Coronary Intervention in comparison to Optimal Medical Therapy for the management of patients with Multi-Vessel Disease. (HTAIn Secretariat)

    • 22. EuroQol-EQVT study to develop Indian Value sets for EQ-5D quality of life scores. (PGIMER Chandigarh)

    • 23. Health Technology Assessment of Intravenous Tranexamic Acid use in management of primary post-partum Haemorrhage in India. (NIRRH, Mumbai)

    • 24. Implementation of blood counters for diagnosis of Dengue at primary health care settings in Tamil Nadu state. Implementation of Thrombocytopenia screening at PHC level. (NIRT, Chennai)

    • 25. Health Technology Assessment of TeCHO plus program in Gujarat State. (IIPH, Gandhinagar)

    • 26.Costing of Health Care Services in Tertiary Hospital.

    • 27. Feasibility and effectiveness of Community-based screening for Chronic Kidney diseases. (JIPMER, Puducherry)

    • 28. Health technology assessment report on clinical effectiveness and cost-effectiveness of cholecystectomy compared with conservative management in people presenting with uncomplicated symptomatic gallstones (biliary pain) or Cholecystitis in India. (NIE, Chennai)

    • 29. HTA on available technologies for detection of Diabetic Retinopathy from colour fundus photographs to prevent blindness in India. (SCTIMST, Trivandrum)

    • 30. Estimation of recurrent cost for institutional delivery in different levels of Facilities under JSSK Scheme. (HTAIn Secretariat)

    • 31. Cost Analysis of the Meghalaya Health Benefit Packages. (IIPH Shillong)

    • 32. Life cost Analysis and HTA of COVID-19 diagnostic tools in India. (HTAIn Secretariat)

    • 33. Life cost Analysis and HTA of COVID-19 COBAS and RT-PCR. (HTAIn Secretariat)

2022

  • 34. The Health Technology Assessment of a Paediatric Cardiac Surgery program (HRIDYAM) for Congenital Heart Disease in Kerala. (SCTIMST, Trivandrum)

  • 35. Cost-Effectiveness Analysis of Rapid Diagnostic Kits with Antimicrobial Sensitivity as Point-of-Care Testing in uncomplicated Urinary Tract Infection. (JIPMER, Puducherry)

  • 36. Health Technology Assessment of Telemedicine-Enabled Otoscope (TEO) for Prevention for Ear Diseases. (RMRC, Bhubaneshwar)

  • 37. Health Technology Assessment of Strategies for Oral Cancer Screening in India. (SCI, Lucknow)

  • 38. Clinical Effectiveness and Cost Effectiveness of delivering Inj. Gentamicin in Neonatal Sepsis by ANMs Before Referral. (AIIMS, Jodhpur)

  • 39. Health Technology Assessment on Positron Emission Tomography and Computed Tomography (PET-CT) for Cancer care in India. (KIHT, Vishakhapatnam)

  • 40. Economic evaluation of Trans-Catheter Aortic Valve Replacement (TAVR) compared to Surgical Aortic Valve Replacement (SAVR) among intermediate and high risk patients with Aortic Stenosis (AS) in India. (AIIMS, Rishikesh)

  • 41. Cost -effectiveness of Parenteral Iron Therapy for First- line Management of Iron Deficiency Anemia among Pregnant Women in a Natural Programme Setting in Gujarat. (IIPH, Gandhinagar)

  • 42. Improving adherence through Tuberculosis Medication Regimen using Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD). (IIPH, Gandhinagar)

  • 43. Health Technology Assessment to determine Cost-effectiveness of Rapid Diagnostic Tests (Hemo-Type-Sc, Sickle Scan and Gazelle) in comparison to solubility test followed by HPLC for Sickle Cell Disease/Trait diagnosis in high-risk population. (HTAIn Secretariat, NIRRH Mumbai, PGIMER Chandigarh)

  • 44. Establishing Proton Technology Equipment for Cancer treatment-Is this treatment cost-effective? : A Rapid Health technology Assessment (PGIMER, Chandigarh)

  • 45. Cost-effectiveness analysis & Value-Based Pricing for Anti-Cancer Drugs: Implications for Patients, Industry, Insurer and Regulator (PGIMER, Chandigarh)

  • 46.Assessment of economic burden and Quality of Life among cancer patients in India: National Cancer Database for Costs and Quality of Life (CaDCQoL)

2023

  • 47.To determine cost effectiveness of rapid diagnostic test HPOS (Sicklecert) in comparison to solubility test followed by HPLC for Sickle cell diagnosis

  • 48.Health Technology Assessment on Latent TB Infection Tests Assessing the Costeffectiveness of Latent TB Infection Tests (LTBI) in India.

  • 49. Health Technology Assessment of Telemedicine-Enabled Otoscope (TEO) for Prevention for Ear Diseases. (RMRC, Bhubaneshwar)49. Assessing the cost-effectiveness of the new treatment BPaLM/BPaL for Multi-drug resistant, rifampicin resistant, tuberculosis (MDR-RR-TB) as compared to the currently used oral Bedaquiline containing regimen under the National Tuberculosis Elimination Programme (NTEP)

  • 50.Cost-effectiveness of linking HIV to Family Planning services to prevent unintended pregnancies in people living with HIV women.

  • 51.Cost-effectiveness of rubella vaccination among women in Maharashtra

  • 52.Health Technology Assessment of Rotational Atherectomy for Undilatable Lesions 49. Evaluation and Management of Phase- 2 Drug-Resistant Epilepsy: Health Technology Assessment Perspective

  • 53.Cost-Effectiveness of Neuromodulator for epilepsy/ Deep Brain Stimulation

  • 54.Health technology assessment of Intermittent Auscultation (IA) techniques (Pinard stethoscope, Doppler) for fetal heart rate monitoring against Cardiotocography (continuous/admission) among women without risk factor on their admission to the labour ward in India.

  • 55.Cost effectiveness analysis of inducing therapeutic hypothermia using Phase Changing Material (MiraCradle) to reduce mortality and neurodevelopmental morbidity in moderate and severe Hypoxic-Ischaemic Encephalopathy (HIE)

  • 56. HTA proposal On Cost-Effectiveness of Deep Brain Stimulation for Parkinson's disease in India

By Category

Medical Devices

    • 1.Health Technology Assessment of Intraocular Lenses for treatment of age related cataracts in India. (HTAIn Secretariat, 2018)

    • 2.Cost effectiveness of Safety Engineered Syringes for therapeutic use on India. (HTAIn Secretariat, 2018)

    • 3.Expanding Informed Contraceptive Choice for Indian Women: Health Technology Assessment of Long Acting Reversible Contraceptives (LARC) in India. (NIRRH, Mumbai)

    • 4.Health Technology Assessment of Automated Resuscitation Device for Neonatal Resuscitation at point of delivery in Indian healthcare system. (KIHT, Vizag,Vishakhapatnam, 2020)

    • 5.Health Technology Assessment of Uterine Balloon Tamponade for management of Postpartum Haemorrhage in India. (NIRRH, Mumbai, 2020)

    • 6. A comprehensive HTA of Project Lifeline - A portable ECG facility at PHCs of Ahmedabad district of Gujarat. (IIPH, Gandhinagar, 2021)

    • 7.Health Technology Assessment of Low Cost Portable Ventilators. (KIHT, Vishakhapatnam, 2021)

    • 8.Health Technology Assessment of Telemedicine-Enabled Otoscope (TEO) for Prevention for Ear Diseases. (RMRC, Bhubaneshwar, 2022)

    • 9.Establ ishing Proton Technology Equipment for Cancer Treatment - Is this treatment cost-effective? A Rapid Health Technology Assessment (PGIMER, Chandigarh, 2022)

Diagnostic Devices

    • 10.Cost effectiveness analysis of Hypothermia detection devices (BEPMU, Thermospot and Fever Watch) for pre-mature and low birth weight neonates in India. (IIPH Shillong, 2020)

    • 11.Health Technology Assessment of portable automated ABR neonatal hearing screening device (Sohum). (RMRC, Bhubaneshwar, 2020)

    • 12.Diagnostic efficacy of digital Hemoglobinometer (TrueHb), Hemocue and non-invasive devices for screening patients for Anaemia in the field settings. (IIPH, Delhi, 2019)

    • 13.Rapid Health Technology Assessment for incorporating TrueNat as a diagnostic tool for tuberculosis under NTEP in India. (HTAIn Secretariat, 2020)

    • 14.Evaluation of Pulse Oximetry as a tool to prevent childhood pneumonia related morbidity and mortality. (SCTIMST, Trivandrum, 2020)

    • 15.Health Technology Assessment of various RT-PCR kits for the diagnosis of Influenza A/H1N1- pdm09 virus in all age patients in India. (NIV Pune, 2020)

    • 16.Cost-Effectiveness Analysis of Rapid Diagnostic Kits with Antimicrobial Sensitivity as Point-of- Care Testing in uncomplicated Urinary Tract Infection. (JIPMER, Puducherry,2022)

    • 17.Health Technology Assessment on Positron Emission Tomography and Computed Tomography (PET-CT) for Cancer care in India. (KIHT, Vishakhapatnam,2022)

Surgical Interventions, Procedures

    • 18.Economic Evaluation of Percutaneous Coronary Intervention(PCI) in comparison to Coronary Artery Bypass Graft (CABG)surgery in Left main with or without Triple Vessel Disease. (HTAIn Secretariat, 2021)

    • 19.Economic Evaluation of Percutaneous Coronary Intervention(PCI) in comparison to Optimal Medical Therapy(OMT) for the management of patients with Single-Vessel Disease without left main coronary artery involvement. (HTAIn Secretariat, 2021)

    • 20.Economic Evaluat ion of Coronary Artery Bypass Graf t surgery and Percutaneous Coronary Intervention in comparison to Optimal Medical Therapy for the management of patients with Multi-Vessel Disease. (HTAIn Secretariat, 2021)

    • 21.Health technology assessment report on clinical effectiveness and cost-effectiveness of cholecystectomy compared with conservative management in people presenting with uncomplicated symptomatic gallstones (biliary pain) or Cholecystitis in India. (NIE, Chennai,2021)

    • 22.Economic evaluation of Trans-Catheter Aortic Valve Replacement (TAVR) compared to Surgical Aortic Valve Replacement (SAVR) among intermediate and high risk patients with Aortic Stenosis (AS) in India. (AIIMS, Rishikesh,2022)

    • 23.HTA on available technologies for detection of Diabetic Retinopathy from colour fundus photographs to prevent blindness in India. (SCTIMST, Trivandrum,2021)

Guidelines

    • 24.Clinical Effectiveness and Cost Effectiveness of delivering Inj. Gentamicin in Neonatal Sepsis by ANMs Before Referral. (AIIMS, Jodhpur,2022)

    • 25.Device specification & Quality Assurance Guidelines for Blood Pressure, Blood Glucose & BMI measuring devices. (SCTIMST, Trivandrum,2019)

Screening Strategies

    • 26.Health Technology Assessment of strategies for Cervical Cancer Screening in India. (PGIMER Chandigarh, 2019)

    • 27.Health Technology Assessment for screening of Type-2 Diabetes & Hypertension in India. (PGIMER Chandigarh, 2020)

    • 28.Health Technology Assessment for screening of Hepatitis B and C at Primary Health Centres (PHC) in Tamil Nadu. (NIRT, Chennai, 2021)

    • 29.Implementation of blood counters for diagnosis of Dengue at primary health care settings in Tamil Nadu state. Implementation of Thrombocytopenia screening at PHC level. (NIRT, Chennai, 2021)

    • 30.Feasibility and effectiveness of Community-based screening for Chronic Kidney diseases. (JIPMER, Puducherry,2021)

    • 31.Health Technology Assessment of Strategies for Oral Cancer Screening in India. (SCI, Lucknow, 2022)

Health Programmes

    • 32.Health Technology Assessment of TeCHO plus program in Gujarat State. (IIPH, Gandhinagar,2021)

    • 33.The Health Technology Assessment of a Paediatric Cardiac Surgery program (HRIDYAM) for Congenital Heart Disease in Kerala. (SCTIMST, Trivandrum,2022)

    • 34.Cost -effectiveness of Parenteral Iron Therapy for First- line Management of Iron Deficiency Anaemia among Pregnant Women in a Natural Programme Setting in Gujarat. (IIPH, Gandhinagar,2022)

    • 35.Improving adherence through Tuberculosis Medication Regimen using Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD). (IIPH, Gandhinagar,2022)

    • 36.Health Technology Assessment to determine Cost-effectiveness of Rapid Diagnostic Tests (Hemo-Type-Sc, Sickle Scan and Gazelle) in comparison to solubility test followed by HPLC for Sickle Cell Disease/Trait diagnosis in high-risk population. (HTAIn Secretariat, NIRRH Mumbai, PGIMER Chandigarh)

Costing Studies

    • 37.Costing of Healthcare services in India (CHSI) Phase 1. (PGI Chandigarh, 2019)

    • 38.Estimation of recurrent cost for institutional delivery in different levels of Facilities under JSSK Scheme. (HTAIn Secretariat,2021)

    • 39.Cost Analysis of the Meghalaya Health Benefit Packages. (IIPH Shillong,2021).

Drugs

    • 40.Health Technology Assessment of Intravenous Tranexamic Acid use in management of primary post-partum Haemorrhage in India. (NIRRH, Mumbai, 2021)

    • 41.Cost-effectiveness analysis & value based pricing for Anti-cancer drugs: Implications for Patients, Industry, Insurer and regulator.

Health Related Quality of Life (HRQoL) Studies

    • 42.EuroQol-EQVT study to develop Indian Value sets for EQ-5D quality of life scores. (PGIMER Chandigarh, 2021)

Pandemic Support

    • 43.Life cost Analysis and HTA of COVID-19 diagnostic tools in India. (HTAIn Secretariat, 2019)

    • 44.Life cost Analysis and HTA of COVID-19 COBAS and RT-PCR. (HTAIn Secretariat, 2019)